:,,,/

Baoxi Zhang1, Yifei Xie1, Weiwen Ji1

  • 1Beijing Key Laboratory of Innovative Drug Discovery and Polymorphic Research for Cerebrovascular Diseases, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Molecular pharmaceutics
|November 21, 2025
PubMed
概括

晶体工程改善了素 (CHR) 的溶解性和可用性. 该CHR-SOP共晶体显示显著增强的溶解性和溶解率,标记它为进一步制药研究的有希望的候选人.